MedTrace Logo

Amphetamine Cocaine Interaction Study - 2

NCT00000305 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2012-05-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Dextroamphetamine

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Texas

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • John Grabowski, Ph.D. · University of Texas

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000305 on ClinicalTrials.gov